Abstract
Most chemotherapeutic agents function either by depriving cells of an adequate quantity of metabolic precursors, e.g., purine, pyrimidine, and folate antagonists, or by modifying the structures of existing cellular components, e.g., alkylating and intercalating agents. Enzymes have been used in experimental therapeutic trials following these same mechanistic principles. Asparaginase, glutaminase, arginase, methioninase, ß-tyrosinease, phenylalanine ammonia lyase, xanthine oxidase, and a folic-acid-degrading enzyme (carboxypeptidase G) have been used to deprive cells of metabolic precursors, while DNase, RNase, neuraminidase, proteolytic enzymes, abrin, ricin, and diphtheria toxin have been used to modify existing cellular components. Enzymes differ from other chemotherapeutic agents, however, in that their macromolecular nature probably restricts their cellular permeability and consequently their accessibility to substrates. This very macromolecular nature enables enzymes to demonstrate a high degree of substrate specificity that can be very useful in restricting their cytotoxicity toward specific tissues, e.g., asparaginase therapy of asparagine-dependent leukemia cells.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Abell, C. W., Stith, W. J., and Hodgkins, D. S., 1972, The effects of phenylalanine ammonia-lyase on leukemic lymphocytes in vitro, Cancer Res. 32: 285.
Abell, C. W., Hodgkins, D. S., and Stith, W. J., 1973, An in vivo evaluation of the chemotherapeutic potency of phenylalanine ammonia-lyase, Cancer Res. 33: 2529.
Adamson, R. H., and Fabro, S., 1968, Antitumor activity and other biologic properties of L-asparaginase (NSC-109229)—a review, Cancer Chemother. Rep. 52 (6): 617.
Arnon, R., and Neurath, H., 1970, Immunochemical studies on bovine trypsin and trypsinogen derivatives, Immunochemistry 7: 241.
Ashworth, L. A. E., and Maclennan, A. P., 1974, Comparison of the L-asparaginases from Escherichia coli and carotovora as immunosuppressants, Cancer Res. 34: 1353.
Astaldi, G., 1972, Is L-asparaginase an antiblastic agent? Haematologia 6: 433.
Astaldi, G., Burgio, G. R., Krc, J., Genova, R., and Astaldi, A. A., Jr., 1969, L-Asparaginase and blastogensis, Lancet 1: 423.
Baechtel, F. S., Gregg, D. E., and Prager, M. D., 1976, The influence of glutamine, its decomposition products, and glutaminase on the transformation of human and mouse lymphocytes, Biochim. Biophys. Acta 421: 33.
Bartholeyns, J., and Baudhuin, P., 1976, Inhibition of tumor cell proliferation by dimerized ribonuclease, Proc. Natl. Acad. Sci. U.S.A. 73: 573.
Becker, F. F., and Broome, J. D., 1967, L-Asparaginase: Inhibition of early mitosis in regenerating rat liver, Science 156: 1602.
Beerman, T. A., and Goldberg, I. H., 1974, DNA strand scission by the antitumor protein neocarzinostatin, Biochem. Biophys. Res. Commun. 59: 1254.
Bekesi, J. G., Holland, J. F., Cuttner, J., Silver, R., Coleman, M., Jarowski, C., and Vinceguerra, V., 1976, Immunotherapy in acute myelocytic leukemia (AML) with neuraminidase (N’ASE) treated allogenic myeloblasts with or without MER, Proc. Amer. Assoc. Cancer Res. 35: 184.
Bergel,-F., 1961, Chemistry of Enzymes in Cancer, pp. 65–70, Charles C Thomas, Springfield, Illinois.
Bernard, J., Boiron, M., Jacquillat, C., Weil, M., and Levy D. (eds.), 1970, La L-Asparaginase, Editions du Centre National de la Recherche Scientifique, Paris.
Bertino, J. R., Skeel, R., Makulu, D., Mcintosh, S., Uhoch, J., and Chabner, B., 1974, Initial clinical studies with carboxypeptidase G, (CPG,): A folate depleting enzyme, Clin. Res. 22: 483a.
Bettigole, R. E., Himelstein, E. S., Oettgen, H. F., and Clifford, G. O., 1970, Hypofibrinogenemia due to L-asparaginase: Studies of fibrinogen survival using autologous “’I-fibrinogen, Blood 35: 195.
Betz, J. L., Brown, P. R., Smyth, M. J., and Clarke, P. H., 1974, Evolution in action, Nature (London) 247: 261.
Blumberg, N., 1974, Tumor angiogenesis factor: Speculations on an approach to cancer chemotherapy, Yale J. Biol. Med. 47: 71.
Bosmann, H. B., 1972, Antineoplastic drug activity in the mitotic cycle—effects of six agents on macromolecular synthesis in synchronous mammalian leukemic cells, Biochem. Pharmacol. 21: 1977.
Boyer,H. W., 1974, Restriction and modification of DNA: Enzymes and substrates, Fed. Proc. Fed. Amer. Soc. Exp. Biol.33:1125.
Broome, J. D., 1963a, Evidence that the L-asparaginase of guinea pig serum is responsible for its antilymphoma effects. I. Properties of the L-asparaginase of guinea pig serum in relation to those of the antilymphoma substance, J. Exp. Med. 118: 99.
Broome, J. D., 1963b, Evidence that the L-asparaginase of guinea pig serum is responsible for its antilymphoma effects. II. Lymphoma 6C3HED cells cultured in a medium devoid of L-asparagine lose their susceptibility to the effects of guinea pig serum in vivo, J. Exp. Med. 118: 121.
Burchenal, J. H., Clarkson, B. D., Dowling, M. D., Gee, T., Haghbin, M., and Tan, C. T. C., 1970, Experimental and clinical studies of L-asparaginase in combination therapy, in: La L-Asparaginase ( J. Bernard, M. Boiron, C. Jacquillat, M. Weil, and D. Levy, eds.), pp. 243–248, Editions de Centre National de la Recherche Scientifique, Paris.
Burns, R. 0., 1971, L-Threonine deaminase—biosynthetic (Salmonella typhimurium), in: Methods in Enzymology (H. Tabor and C. W. Tabor, eds.), Vol. 17B, pp. 555–560, Academic Press, New York.
Buzzi, S., and Maistrello, I., 1973, Inhibition of growth of Ehrlich tumors in Swiss mice by diphtheria toxin, Cancer Res. 33: 2349.
Capizzi, R. L., 1975, Improvement in the therapeutic index of L-asparaginase by methotrexate, Cancer Chemother. Rep. 6 (3): 37.
Capizzi, R. L., Bertino, J. R., and Handschumacher, R. E., 1970, L-Asparaginase, Annu. Rev. Med. 21: 433.
Capizzi, R. L., Summers, W. P., and Bertino, J. R., 1971, L-Asparaginase induced alteration of methotrexate activity in mouse leukemia L5178Y, Ann. N. Y. Acad. Sci. 186: 302.
Capizzi, R., Castro, 0., Aspnes, G., Bobrow, S., Bertino, J., Finch, S., and Pearson, H., 1974, Treatment of acute lymphocytic leukemia (ALL) with intermittent high dose methotrexate (MTX) and asparaginase, Proc. Amer. Assoc. Cancer Res. 15: 182.
Chabner, B. A., Chello, P. L., and Bertino, J. R., 1972a, Antitumor activity of a folate-cleaving enzyme, carboxypeptidase G1, Cancer Res. 32: 2114.
Chabner, B. A., Johns, D. G., and Bertino, J. R., 1972b, Enzymic cleavage of methotrexate provides a method for prevention of drug toxicity, Nature (London) 239: 395.
Chang, P. K., 1976, O-L-Homoserine-5’-adenylate (USAMP). Esterification of 5’-adenylic acid with the gamma-hydroxyl group of L-homoserine, in: Synthetic Procedures in Nucleic Acid Chemistry, Vol. III ( L. Townsend, ed.), John Wiley and Sons, New York.
Chang, T. M. S., 1971, The in vivo effects of semipermeable microcapsules containing L-asparaginase on 6C3HED lymphosarcoma, Nature (London) 229: 117.
Chen, L. F., and Richardson, T., 1974, Enzyme derivatives containing reactive groups. Immobilization of alpha-amylase on human erythrocytes, Pharmacol. Res. Commun. 6: 273.
Chong, E. O. S., and Chang, T. M. S., 1974, In vivo effects of intraperitoneally injected Lasparaginase solution and L-asparaginase immobilized within semipermeable nylon microcapsules with emphasis on blood L-asparaginase, “body” L-asparaginase, and plasma L-asparagine levels, Enzyme 18: 218.
Chou, T. C., and Handschumacher, R. E., 1972, Production of L-asparagine by tumor cells and the effect of asparagine analogs, Biochem. Pharmacol. 21: 39.
Cooney, D. A., and Handschumacher, R. E., 1970, L-Asparaginase and L-asparagine metabolism, Annu. Rev. Pharmacol. 10: 421.
Cooney, D. A., and Rosenbluth, R. J., 1975, Enzymes as therapeutic agents, Adv. Pharmacol. Chemother. 12: 185.
Cooney, D. A., Capizzi, R. L., and Handschumacher, R. E., 1970, Evaluation of L-asparagine metabolism in animals and man, Cancer Res. 30: 929.
Demopoulos, H. B., 1966a, Effects of low phenylalanine–tyrosine diets on S91 mouse melanomas, J. Natl. Cancer Inst. 37: 185.
Demopoulos, H. B., 1966b, Effects of reducing the phenylalanine–tyrosine intake of patients with advanced malignant melanoma, Cancer 19: 657.
Deodhar, S. D., 1973, Enhancement of metastases by L-asparaginase in allogeneic and isogeneic mouse tumor systems, Adv. Exp. Med. Biol. 29: 519.
Distasio, J. A., and Niederman, R. A., 1976, Purification and characterization of L-asparaginase with antilymphoma activity from Vibrio succinogenes, J. Biol. Chem. 251: 6929.
Ellison, R. R., Karnofsky, D. A., Sternberg, S. S., Murphy, M. L., and Burchenal, J. H., 1954, Clinical trials of O-diazoacetyl-L-serine (azaserine) in neoplastic disease, Cancer 7: 801.
Engasser, J.-M., and Horvath, C., 1976, Diffusion and kinetics with immobilized enzymes, in: Applied Biochemistry and Bioengineering, Vol. I (L. B. Wingard, Jr., E. Katzir-Katchalski, and L. Goldstein, eds.), pp. 127–220, Academic Press, New York.
Feinstein, G., Bodlaender, P., and Shaw, E., 1969, The modification of essential carboxylic acid side chains of trypsin, Biochemistry 8: 4949.
Foley, G. E., Barell, E. F., Adams, R. A., and Lazarus, H., 1969, Nutritional requirements of human leukemic cells. Cystine requirements of diploid cell lines and their heteroploid variants, Exp. Cell Res. 57: 129.
Gerhart, J. C., and Schachman, H. K., 1965, Distinct subunits for the regulation and catalytic activity of aspartate transcarbamylase, Biochemistry 4: 1054.
Gill, D. M., Pappenheimer, A. M., and Uchida, T., 1973, Diphtheria toxin, protein synthesis, and the cell, Fed. Proc. Fed. Amer. Soc. Exp. Biol. 32: 1508.
Goldberg, A. I., Cooney, D. A., Glynn, J. P., Homan, E. R., Gaston, M. R., and Milman, H. A., 1973, The effects of immunization to L-asparaginase on antitumor and enzymatic activity, Cancer Res. 33: 256.
Goldstein, A., Aronow, L., and Kalman, S., 1974, Principles of Drug Action: The Basis of Pharmacology, p. 166, John Wiley and Sons, New York.
Greenberg, D. M., and Sassenrath, E. N., 1953, Lack of effect of high potency arginase on tumor growth, Cancer Res. 13: 709.
Grundmann, E., and Oettgen, H. F. (eds.), 1970, Experimental and Clinical Effects of L-Asparaginase, Springer-Verlag, New York—Heidelberg-Berlin.
Gumprecht, J. G., and Wriston, J. C., 1973, Purification and partial sequencing of cyanogen bromide peptides from L-asparaginase of Escherichia coli, Biochemistry 12: 4869.
Haddow, A., Lamirande, G. P., Bergel, F., Bray, R. C., and Gilbert, D. A., 1958, Antitumor and biochemical effects of purified bovine xanthine oxidase in C3H and C mice, Nature (London) 182: 1144.
Haley, E. E., Fischer, G. A., and Welch, A. D., 1961, The requirement for L-asparagine of mouse leukemia cells L5178Y in culture, Cancer Res. 21: 532.
Halpern, B. C., Clark, B. R., Hardy, D. N., Halpern, R. M., and Smith, R. A., 1974, The effect of replacement of methionine by homocystine on survival of malignant and normal adult mammalian cells in culture, Proc. Natl. Acad. Sci. U.S.A. 71: 1133.
Han, T., and Ohnuma, T., 1972, L-Asparaginase: In vitro inhibition of blastogenesis by enzyme from Erwinia catotovora, Nature (London) New Biol. 239: 50.
Hare, L. E., and Handschumacher, R. E., 1973, Physical and biological properties of acetamidino-, f3dimethylaminopropionamidino-, and maleyl-L-asparaginase, Mol. Pharmacol. 9: 534.
Haskell, C. M., and Canellos, G. P., 1969, L-Asparaginase resistance in human leukemia—asparagine synthetase, Biochem. Pharmacol. 18: 2578.
Haskell, C. M., Canellos, G. P., Leventhal, B. G., Carbone, P. P., Block, J. B., Serpick, A. A., and Selawry, O. S., 1969, L-Asparaginase: Effects in patients with neoplastic disease, N. Engl. J. Med. 281: 1028.
Hayashi, O., 1955, Special techniques for bacterial enzymes. Enrichment culture and adaptive enzymes, in: Methods in Enzymology ( S. P. Colowick and N. O. Kaplan, eds.), Vol. 1, pp. 126–137, Academic Press, New York.
Hegeman, G. D., and Rosenberg, S. L., 1970, The evolution of bacterial enzyme systems, Annu. Rev. Microbiol. 24: 429.
Hersh, E. M., 1971, L-Glutaminase: Suppression of lymphocyte blastogenic responses in vitro, Science 172: 736.
Hersh, E. M., 1973, Immunosuppressive enzymes, Transplant. Proc. 5: 1211.
Herter, F. P., Weissman, S. G., Thompson, H. G., Hyman, G., and Martin, D. S., 1961, Clinical experience with 6-amino nicotinamide, Cancer Res. 21: 31.
Ho, P. H. W., Thetford, B., Carter, C. J. K., and Frei, E., 1970, Clinical pharmacologic studies of L-asparaginase, Clin. Pharmacol. Ther. 11: 408.
Ho, P. P. K., and Millikin, E. B., 1970, Multiple forms of L-asparaginase, Biochim. Biophys. Acta 206: 196.
HOLCENBERG, J. S., AND ROBERTS, J., 1977, Enzymes as drugs, Annu. Rev. Pharmacol. 17.
Holcenberg, J. S., Roberts, J., and Dolowy, W. C., 1973, Glutaminases as antineoplastic agents, in: The Enzymes of Glutamine Metabolism ( S. Prusiner and G. Stadtman, eds.), pp. 277–292, Academic Press, New York and London.
Holcenberg, J. S., Schimer, G., Teller, D. C., and Roberts, J., 1975a, Biologic and physical properties of succinylated and glycosylated Acinetobacter glutaminase-asparaginase, J. Biol. Chem. 250: 4165.
Holcenberg, J. S., Tang, E., and Dolowy, W. C., 1975b, Effect of Acinetobacter glutaminase-asparaginase treatment on free amino acids in mouse tissues, Cancer Re. 35: 1320.
Horowitz, B., and Meister, A., 1972, Glutamine-dependent asparagine synthetase from leukemia cells, J. Biol. Chem.247:6708.
Horowitz, B., Madras, B. K., Meister, A., Old, L. S., Boyce, E. A., and Stockert, E., 1968, Asparagine synthetase activity of mouse leukemias, Science 160: 533.
Howard, J. B., and Carpenter, F. H., 1972, L-Asparaginase from Erwinia carotovora. Substrate specificity and enzymatic properties, J. Biol. Chem. 247: 1020.
Ihler, G. M., Glew, R. H., and Schnure, F. W., 1973, Enzyme loading of erythrocytes, Proc. Natl. Acad. Sci. U.S.A. 70: 2663.
Ihler, G. M., Lantzy, A., Purpura, J., and Glew, R. H., 1975, Enzymatic degradation of uric acid by urease-loaded human erythrocytes, J. Clin. Invest. 56: 595.
Jackson, R. C., and Handschumacher, R. E., 1970, Escherichia coli L-asparaginase. Catalytic activity and subunit nature, Biochemistry 9: 3585.
Jose, D. G., and Good, R. A., 1973, Quantitative effects of nutritional essential amino acid deficiency upon immune responses to tumors in mice, J. Exp. Med. 137: 1.
Kendall, P. A., 1972, Antibody labelling for electron microscopy: Immunochemical properties of immunoglobulin G heavily labeled with methylmercury after thiolation by homocysteine thiolactone, Biochim. Biophys. Acta 257: 101.
kidd, J. D., 1953, Regression of transplanted lymphomas induced in vivo by means of normal guinea pig serum, J. Exp. Med. 98: 565.
Kolata, G. B., 1975, Intracellular bacterial toxins: Origins and effects, Science 190: 969.
Kreis, W., and Hession, C., 1973a, Isolation and purification of L-methionine-a-deamino-y-mercaptomethane-lyase (L-methionase) from Clostridium sporogenes, Cancer Res. 33: 1862.
Kreis, W., and Hession, C., 1973b, Biological effects of enzymatic deprivation of L-methionine in cell culture and an experimental tumor, Cancer Res. 33: 1866.
Laboureur, P., Langlois, C., Labrousse, M., Boudon, M., Emeraud, J., Samain, J. F., Ageron, M., and Dumesnil, Y., 1971, L-Asparaginases d’Escherichia coli. II. Pluralite et origine des formes moleculaires. Relations avec l’activite biologique, Biochimie 53: 1157.
Lamirande, G. D., 1961, Action of deoxyribonuclease and ribonuclease on the growth of Ehrlich ascites carcinoma in mice, Nature (London) 192: 52.
Land, V. J., Sutow, W. W., Fernbach, D. J., Lane, D. M., and Williams, T. E., 1972, Toxicity of L-asparaginase in children with advanced leukemia, Cancer 30: 339.
Lane, M., and Smith, F. E., 1971, Induced riboflavin deficiency in treatment of patients with lymphomas and polycythemia vera, Proc. Amer. Assoc. Cancer Res. 12: 85.
Lane, M., Alfrey, C. P., Mengel, C. E., Doherty, M. A., and Doherty, J., 1964, The rapid induction of human riboflavin deficiency with galactoflavin, J. Clin. Invest. 43: 357.
Lazarus, H., Barell, E. F., Oppenheim, S., and Krishan, A., 1974, Divergent properties of two human lymphocytic cell lines isolated from a single specimen of peripheral blood, In Vitro 9: 303.
Levin, B., and Merrill, J. P., 1972, Immunosuppressive effects of cyclophosphamide and Lasparaginase in the inbred rat renal transplant model, Transplantation 13: 160.
Lin, J. Y., Tserng, K. Y., Chen, C. L., Lin, L. T., and Tung, T. C., 1970, Abrin and ricin: New antitumor substances, Nature (London) 227: 292.
Ltu, Y. P., and Handschumacher, R. E., 1972, Nitroasparaginase: Subunit cross-linkage and altered substrate specificity, J. Biol. Chem. 247: 66.
Livingston, D. M., Ferguson, C., Gallogly, R., and Lazarus, H., 1976, Accumulation of cystine auxotrophic thymocytes accompanying Type C viral leukemogenesis in the mouse, Cell 7: 41.
Lorincz, A. B., Kuttner, R. E., and Brandt, M. B., 1969, Tumor response to phenylalanine-tyrosine limited diets, J. Amer. Diet. Assoc. 54: 198.
Malta, T., Morokuma, K., and Matsuda, G., 1974, Amino acid sequence of L-asparaginase from Escherichia coli, J. Biochem. 76: 1351.
Makino, H., Satoh, H., Kuroiwa, Y., Yanazaki, S., Tamaura, Y., and Inada, Y., 1975, Immunochemical properties of asparaginase modified by chemical substitutions, Immunochemistry 12: 183.
Manning, J. M., Cerami, A., Gillette, P. N., Defuria, F. G., and Miller, D. R., 1974, Biochemical and physiological properties of carbamylated hemoglobin S, Adv. Enzymol. 40: 1.
Marsh, J. W., Denis, I., and Wriston, J. C., 1976, Effect of glycosylation on clearance of E. coli asparaginase in mice, Fed. Proc. 35: 1371.
Mashburn, L. T., and Wriston, J. C., 1964, Tumor inhibitory effect of L-asparaginase from Escherichia coli, Arch. Biochem. Biophys. 105: 450.
Mccoll, J. D., Rice, W. B., and Adamkiewicz, V. W., 1957, Inhibition of Walker carcinoma 256 by 6-amino nicotinamide, Can. J. Biochem. 35: 795.
Mccullough, J. L., Chabner, B. A., and Bertino, J. R., 1971, Purification and properties of carboxypeptidase G,, J. Biol. Chem. 246: 7207.
Meadows, G. G., Digiovanni, J., Minor, J., and Elmer, G. W., 1976, Some biological properties and an in vivo evaluation of tyrosine phenol-lyase on growth of B-16 melanoma, Cancer Res. 36: 167.
Mihich, E., and Nichol, A. A., 1965, Antitumor effects of methylglyoxal-bis-(N4methylthiosemicarbazone) and their potentiation in pyridoxine-deficient animals, Cancer Res. 25: 794.
Mikami, T., Ohuma, M., and Hayashi, T. T. A., 1974, Requirement of arginine for the replication of Marek’s disease herpes virus, J. Gen. Virol. 22: 115.
Miller, H. K., Salser, J. S., and Balis, M. E., 1969, Amino acid levels following L-asparagine amidohydrolase (EC.3.5.1.1) therapy, Cancer Res. 29: 183.
Morell, A. G., Gregoriadis, G., Scheinberg, I. H. Hickman, J., and Ashwell, G., 1971. The role of sialic acid in determining the survival of glycoproteins in the circulation, J. Biol. Chem. 246: 1461.
Morino, Y., and Snell, E. E., 1970, Tryptophanase (Escherichia coli B), in: Methods in Enzymology ( H. Tabor and C. W. Tabor, eds.), Vol. 17A, pp. 439–446, Academic Press, New York.
Morris, H. P., 1947, Effects on the genesis and growth of tumors associated with vitamin intake, Ann. N. Y. Acad. Sci. 49: 119.
Nesbitt, M., Chard, R., Evans, A., Karon, M., and Hammond, D., 1970, Intermittent L-asparaginase therapy for acute childhood leukemia, Proceedings of the 10th International Cancer Congress, p. 447.
Neukomm, S., Thompson, C. B., and Biossonnaz, M., 1949, Action de l’arginase pure sur la croissance du cancer greffe de la souris, Expezientia 5: 239.
Newman, R. E., and Mccoy, T. A., 1956, Dual requirement of Walker carcinosarcoma 256 in vitro for asparagine and glutamine, Science 124: 124.
Newcomb, E., and Minocha, H. C., 1973, Amino acid requirement for fibroma virus replication in rabbit kidney cells, Amer. J. Vet. Res. 34: 261.
Newton, W. A., Ertel, I. J., Nesbit, M., Thatcher, L. G., Karon, M., and Hammond, G. B., 1973, Effective dose of L-asparaginase in acute leukemia, Proc. Amer. Assoc. Cancer Res. 14: 78.
Ohno, R., and Hersh, E. M., 1970, Immunosuppressive effects of L-asparaginase, Cancer Res.30:1605.
Ohnuma, T., Holland, J. F., Nagel, G., and ST. Arneault, G., 1969, Effects of L-asparaginase in acute myelocytic leukemia, J. Amer. Med. Assoc. 210: 1919.
Ohnuma, T., Waligunda, J., and Holland, J. F., 1971, Amino acid requirements in vitro of human leukemic cells, Cancer Res. 31: 1640.
Ohnuma, T., Holland, J. F., and Meyer, P., 1972, Erwinia carotovora asparaginase in patients with prior anaphylaxis to asparaginase from E. coli, Cancer 30: 376.
Oki, T., Shirai, M., Ohshima, M., Yamamoto, T., and Soda, K., 1973, Antitumor activities of bacterial leucine dehydrogenase and glutaminase A, FEBS Lett. 33: 286.
Old, L. J., Boyse, E. A., Campbell, H. A., Brodey, R. S., Fidler, J., and Teller, J. D., 1967, Treatment of lymphosarcoma in the dog with L-asparaginase, Cancer 20: 1066.
Olsnes, S., Refsnes, K., and Pijl, A., 1974, Mechanism of action of the toxic lectins abrin and ricin, Nature (London) 249: 627.
Ortega, J., Nesbit, M., Donaldson, M., Weiner, J., Hittle, R., and Karon M., 1975, LAsparaginase, vincristine and prednisone for induction of first remission in acute lymphocytic leukemia (ALL), Proc. Amer. Assoc. Cancer Res. 16: 140.
Patterson, M. K., JR., and Orr, G. R., 1969, Regeneration, tumor, dietary and L-asparaginase effects on asparagine biosynthesis in rat liver, Cancer Res. 29: 1179.
Pearsall, N. N., and Weiser, R. S., 1970, The Macrophage, p. 65, Lea and Febiger, Philadelphia. Peterson, R. G., Handschumacher, R. E., and Mitchell, M. S., 1971, Immunological responses to L-asparaginase, J. Clin. Invest. 50: 1080.
Potter, V. R., 1958, The biochemical approach to the cancer problem, Fed. Proc. Fed. Amer. Soc. Exp. Biol. 17: 691.
Prager, M. D., and Bachynsky, N., 1968, Asparagine synthetase in normal and malignant tissues: Correlation with tumor sensitivity to asparaginase, Arch. Biochem. Biophys. 127: 645.
Recsei, P. A., and Snell, E. E., 1970, Histidine decarboxylase of Lactobacillus 30a. VI. Mechanism of action and kinetic properties, Biochemistry 9: 1492.
Regan, J. D., Vodopick, H., Takeda, S., Lee, W. H., and Faulcon, F. M., 1969, Serine requirement in leukemic and normal blood cells, Science 163: 1452.
Rigby, P. W. J., Burleigh, B. D., and Hartley, B. S., 1974, Gene duplication in experimental enzyme evolution, Nature (London) 251: 200.
Riley, V., 1968, Role of the LDH-elevating virus in leukemia therapy by asparaginase, Nature (London) 220: 1245.
Riley, V., Campbell, H. A., and Stock, C. C., 1970, Asparaginase clearance: Influence of the LDH-elevating virus, Proc. Soc. Exp. Biol. Med. 133: 3.
Rivlin, R. S., 1973, Riboflavin and cancer: A review, Cancer Res. 33: 1977.
Rivlin, R. S., Hornibrook, R., and Osnos, M., 1973, Effects of riboflavin deficiency upon concentrations of riboflavin mononucleotide and flavin adenine dinucleotide in Novikoff hepatoma in rats, Cancer Res. 33: 3019.
Roberts, J., 1976, Purification and properties of highly potent antitumor glutaminase—asparaginase from Pseudomonas 7a, J. Biol. Chem. 251: 2119.
Roberts, J., and Schmid, F. A., 1976, Biological and antineoplastic properties of a novel Pseudomonas glutaminase—asparaginase with high therapeutic efficacy, Proc. Amer. Assoc. Cancer Res. 17: 26.
Roberts, J., Schmid, F. A., and Takai, K., 1974, The in vivo effects of leucine dehydrogenase from Bacillus sphaericus, FEBS Letters 43: 56.
Roberts, J., Schmid, F. A., and Takai, K., 1976, In vivo effects of phenylalanine ammonia lyase, Cancer Treatment Rep. 60: 261.
Rogers, J. C., and Kornfeld, S., 1971, Hepatic uptake of proteins coupled to feteuin glycopeptide, Biochem. Biophys. Res. Commun. 45: 622.
Roholt, O. A., and Greenberg, D. M., 1956, Liver arginase. IV. Effects of pH on kinetics of manganese-activated enzyme, Arch. Biochem. Biophys. 62: 454.
Rubens, R. D., 1974, Antibodies as carriers of anticancer agents, Lancet 1974: 498.
Rutter, D. A., and Wade, H. E., 1971, The influence of the iso-electric point of L-asparaginase upon its persistence in the blood, Br. J. Exp. Pathol. 52: 610.
Ryan, W. L., and Curtis, G. L., 1973, Immunity and asparaginase suppression of tumor growth, J. Natl. Cancer Inst. 51: 147.
Sachs, D. H., Schechter, A. N., Eastlake, A., and Anfinsen, C. B., 1974, Immunological distinction between the possible origins of enzymatic activity in a polypeptide fragment of staphylococcal nuclease, Nature (London) 251: 242.
Sagers, R. D., and Carter, J. E., 1971, L-Serine dehydratase (Clostridium acidiurici), in: Methods in Enzymology ( H. Tabor and C. W. Tabor, eds.), Vol. 17B, pp. 351–356, Academic Press, New York.
Sartorelli, A. C., 1964, Combination chemotherapy with actinomycin D and ribonuclease: An example of complementary inhibition, Nature (London) 203:877.
Saunders, E. F., 1972, The effect of L-asparaginase on the nucleic acid metabolism and cell cycle of human leukemia cells, Blood 39: 575.
Schmid, F. A., and Roberts, J., 1974, Antineoplastic and toxic effects of Acinetobacter and Pseudomonas glutaminase-asparaginase, Cancer Chemother. Rep. 58: 829.
Schwartz, R. S., 1969, L-Asparaginase acts as an immunosuppressant in mice, Nature (London) 224: 275.
Sedlacek, H. H., Meesmann, H., and Seiler, F. R., 1975, Regression of spontaneous mammary tumors in dogs after injection of neuraminidase-treated tumor cells, Int. J. Cancer 15: 409.
Seigler, H. F., Shingleton, W. W., and Pickrell, K. L., 1974, Intralesional BCG, intravenous immuno lymphocytes, and immunization with neuraminidase-treated tumor cells to manage melanoma, Plast. Reconstr. Surg. 55: 294.
Sethi, K. K., and Brandis, H., 1973, Neuraminidase induced loss in the transplantability of murine leukemia L1210, induction of immunoprotection and the transfer of induced immunity to normal DBA/2 mice by serum and peritoneal cells, Br. J. Cancer 27: 106.
Shapiro, D. M., Dietrich, L. S., and Shils, M. E., 1957, Quantitative biochemical differences between tumor and host as a basis for cancer chemotherapy, V. Niacin and nicotinamide, Cancer Res. 17: 600.
Shifrin, S., and Grochowski, B. J., 1972, L-Asparaginase from Escherichia coli B. Succinylation and subunit interaction, J. Biol. Chem. 247: 1048.
Shifrin, S., Luborsky, S. W., and Grochowski, B. J., 1971, L-Asparaginase from Escherichia coli B. Physiocochemical studies of the dissociation process, J. Biol. Chem. 246: 7708.
Shingleton, W. W., Seigler, H. F., Stocks, L. H., and Downs, R. W., 1975, Management of recurrent melanoma of the extremity, Cancer 35: 574.
Shizuta, Y., and Tokushige, M., 1971, Threonine deaminase—degradative (Escherichia coli), in: Methods in Enzymology ( H. Tabor and C. W. Tabor, eds.), Vol. 17B, pp. 575–580, Academic Press, New York.
Simmons, R. L., and Rios, A., 1973a, Differential effect of neuraminidase on the immunogenicity of viral associated and private antigens of mammary carcinomas, J. Immunol. 111: 1820.
Simmons, R. L., and Rios, A., 1973b, Neuraminase treated cells and their role in cancer immunotherapy, in: Birth Defects: Original Article Series ( D. Bergsma, ed.), Vol. 9, pp. 223–228, Williams and Wilkins, Baltimore.
Simmons, R. L., Rios, A., Landgren, G., RAY, P. K., Mckhann, C. F., and Haywood, G. R., 1971, Immunospecific regression of methylcholanthrene fibrosarcoma with the use of neuraminidase, Surgery 70: 38.
Skipper, H. E., and Thomson, J. R., 1958, A preliminary study of the influence of amino acid deficiencies on experimental cancer chemotherapy, in: Ciba Found. Symp.: Amino Acids and Peptides with Antimetabolic Activity ( G. E. W. Wolstonholme and C. M. O’Connor, eds.), pp. 38–61, Little, Brown and Co., Boston.
Spiers, A. S. D., and Wade, H. E., 1976, Bacterial glutaminase in treatment of acute leukaemia, Br. Med. J. 1: 1317.
Storr, J. M., and Burton, A. F., 1974, The effects of arginine deficiency on lymphoma cells, Br. J. Cancer 30: 50.
Sugimura, T., Birnbaum, S. M., Winitx, M., and Greenstein, J. P., 1959, Quantitative nutritional studies with water-soluble, chemically defined diets. VIII. The forced feeding of diets each lacking in one essential amino acid, Arch. Biochem. Biophys. 81: 448.
Summers, W. P., and Handschumacher, R. E., 1971, L5178Y asparagine-dependent cells and independent clonal sublines: Toxicity of 5-diazo-4-oxo-L-norvaline, Biochem. Pharmacol. 20: 2213.
Summers, W. P., and Handschumacher, R. E., 1973, The rate of mutation of L5178Y asparagine-independence and its biological consequences, Cancer Res. 33: 1775.
Theuer, R. C., 1971, Effect of essential amino acid restriction on the growth of female C57BL mice and their implanted BW10232 adenocarcinomas, J. Nutr. 101: 223.
Thorbecke, G. J., Maurer, P. H., and Benaceraff, B., 1960, The affinity of the reticulo-endothelial system for various modified serum proteins, Br. J. Exp. Pathol. 41: 190.
Thornes, R. D., Deasy, P. F., Carroll, R., Reen, D. C., and Macdonell, J. D., 1972, The use of the proteolytic enzyme brinase to produce autocytoxicity in patients with acute leukemia and its possible role in immunotherapy, Cancer Res. 32: 280.
Tryfiates, G. P., and Morris, H. P., 1974, Effect of pyridoxine deficiency on tyrosine transaminase activity and growth of four Morris hepatomas, J. Natl. Cancer Inst. 52: 1259.
Uren, J. R., and Handschumacher, R. E., 1974, Evaluation of asparagine analogs as cancer chemotherapeutic agents, Proc. Amer. Assoc. Cancer Res. 15: 124.
Uren, J. R., and Lazarus, H., 1975, Enzymatic approaches to cyst(e)ine depletion therapy, Proc. Amer. Assoc. Cancer Res. 16: 144.
Uren, J. R., Summers, W. P., and Handschumacher, R. E., 1974, Enzymatic and nutritional evidence for two-stage expression of the asparagine synthetase locus in L5178Y murine leukemia mutants, Cancer Res. 34: 2940.
Vadlamudi, S., Padarathsingh, M., Waravdekar, V. S., and Goldin, A., 1970, Factors influencing the therapeutic activity of L-asparaginase (NSC 109229) in leukemic (L5178Y) mice, Cancer Res. 30: 1467.
Vrat; V. A., 1951, Inhibitory effects of arginase on mammary adenocarcinoma transplants in strain A mice, Permanente Found. (Oakland, Calif.) Med. Bull. 9: 49.
Weigelt, 0., 1974, Die Wirkung intratumoral applizierter proteolytischer Enzyme auf spontane Mamma-adenome bei weiblichen Sprague-Dawley Ratten, Arzneim. Forsch. 24: 549.
Whitecar, J. P., Bodey, G. P., Harris, J. E., and Freireich, E. J., 1970, L-Asparaginase, N. Engl. J. Med. 282: 732.
Wolf, M., and Ransberger, K., 1972, Enzyme Therapy, Vantage Press, New York.
Woods, J. S., and Handschumacher, R. E., 1973, Hepatic regulation of plasma L-asparagine, Amer. J. Physiol. 224: 740.
Wriston, J. C., and Yellin, T. 0., 1973, L-Asparaginase: A review, Adv. Enzymol. 39: 185.
Wu, T. T., Lin, E. C. C., and Tanaka, S., 1968, Mutants of Aerobacter aerogenes capable of utilizing xylitol as a novel carbon source, J. Bacteriol. 96: 447.
Wu, W. H., and Morris, D. R., 1973, Biosynthetic arginine decarboxylase from Escherichia coli: Purification and properties, J. Biol. Chem. 248: 1687.
Zyk, N., 1973, Modification of L-asparaginase EC-2 by homologous antibodies, Biochim. Biophys. Acta 302: 420.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1977 Plenum Press, New York
About this chapter
Cite this chapter
Uren, J.R., Handschumacher, R.E. (1977). Enzyme Therapy. In: Becker, F.F. (eds) Chemotherapy. Cancer, vol 5. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-6628-1_16
Download citation
DOI: https://doi.org/10.1007/978-1-4615-6628-1_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-6630-4
Online ISBN: 978-1-4615-6628-1
eBook Packages: Springer Book Archive